Neuren Pharmaceutica...
ASX:NEU
$ 12,52
$-0,06 (-0,48%)
12,52 $
$-0,06 (-0,48%)
End-of-day quote: 04/10/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$0,23
Earnings Per Share
$0,51
Revenue Per Share
43,71%
Gross Margin %
$1,59 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$0,23
Revenue Per Share
$0,51
Gross Margin %
43,71%
Market Cap
$1,59 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
EPS Earnings Per Share $0,23 $1,09 $1,20 $0,00 $-0,07 $-0,09 $-0,11 $0,07 $-0,01 $-0,12 $-0,16 $-0,10 $-0,13
Earnings Earnings $29,13M $138,44M $152,72M $0,00M $-8,82M $-10,31M $-11,02M $7,01M $-0,97M $-11,05M $-14,14M $-8,13M $-9,83M
RPS Revenue Per Share $0,00 $0,51 $1,68 $1,82 $0,14 $0,03 $0,01 $0,01 $0,15 $0,01 $0,01 $0,02 $0,04 $0,07
Revenue Revenue $0,00M $64,63M $213,24M $231,93M $17,03M $3,64M $0,96M $1,02M $15,17M $0,63M $1,31M $1,67M $2,93M $5,24M
OCF Operating Cash Flow $0,00M $129,72M $-11,27M $184,93M $3,60M $-9,97M $-8,08M $-11,72M $6,41M $-5,59M $-12,38M $-12,73M $-6,41M $-7,76M
FCF Free Cash Flow $0,00M $113,57M $-11,28M $175,35M $3,58M $-9,98M $-8,08M $-11,73M $6,41M $-5,59M $-12,39M $-12,73M $-6,44M $-7,78M
OM Operating Margin 0,00% 34,09% 82,63% 85,90% -4,75% -257,52% 0,00% 0,00% 41,57% 0,00% 0,00% 0,00% 0,00% -138,01%
GM % Gross Margin % 0,00% 43,71% 84,79% 88,47% 17,55% -197,65% 0,00% 0,00% 56,39% 0,00% 0,00% 0,00% -241,73% -80,50%
FCFS Free Cash Flow Per Share $0,00 $0,98 $-0,09 $1,45 $0,03 $-0,08 $-0,08 $-0,12 $0,06 $-0,06 $-0,15 $-0,15 $-0,08 $-0,11
LT Debt Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A N/A
Sha. Stocks 126,64M 126,64M 127,01M 127,27M 125,97M 125,97M 114,61M 100,17M 100,17M 97,34M 92,1M 88,35M 81,26M 75,63M
×